BIOSYNGEN (SG) PTE. LTD.
Country of registration | Singapore |
Registration number | 201804019H |
Local SIC | |
Incorporation date | 1 Feb 2018 |
Company age | 8 years 3 months |
Official entity type | Exempt Private Limited Company |
No. of officers | 64 |
Contact
5 TAI SENG AVENUE, #08-51/54, TAI SENG EXCHANGE, Singapore 536671
This is the legal entity page of BIOSYNGEN (SG) PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- BIOSYNGENView MoreSingaporeBiosyngen is a cell therapy company focused on addressing unmet medical needs through innovative technology. Our pipeline includes Phase I/II clinical trials for nasopharyngeal cancer and lymphoproliferative disease, with plans for additional indications. We leverage a dual HQ structure in Singapore and Guangzhou, and have established GMP cell therapy manufacturing facilities in both locations. Our Translational Medicine Centre is a public-private-partnership hub connecting stakeholders in R&D, clinical development, hospitals, pharma, enterprises, and venture capital. Committed to improving patient outcomes, we seek breakthroughs in collaborations and cutting-edge technologies to bring new treatments to market.
Revenue | < 1m |
Share Capital - Ordinary shares | SGD 1,978,035 |
Frequently Asked Questions (FAQ)
- What is the address of BIOSYNGEN (SG) PTE. LTD.?
- Where is BIOSYNGEN (SG) PTE. LTD.'s headquarter?
- What is BIOSYNGEN (SG) PTE. LTD.'s contact number?
- What BIOSYNGEN (SG) PTE. LTD.'s spending power?
- Does BIOSYNGEN (SG) PTE. LTD. have a presence in the domain it operates in?

